Ani Pharmaceuticals (ANIP) Interest Coverage Ratio (2011 - 2026)
Ani Pharmaceuticals (ANIP) posted Interest Coverage Ratio of 1.01 for Q1 2026, down 70.29% sequentially from 3.39 in Q4 2025, and up 78.42% YoY from 0.57 in Q1 2025.
Ani Pharmaceuticals (ANIP) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Interest Coverage Ratio for 16 years, with the latest figure at 1.01 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 78.42% year-over-year to 1.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3.21 (up 2200.79% YoY) and the FY2025 annual result came in at 2.3, up 20177.63% from the prior year.
- Interest Coverage Ratio fell to 1.01 in Q1 2026 per ANIP's latest filing, from 3.39 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 3.39 in Q4 2025 and troughed at 0.56 in Q1 2022.
- A 5-year average of 0.44 and a median of 0.29 in 2025 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio slumped 612.83% in 2022, then jumped 782.11% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 0.13 in 2022, then soared by 70.31% to 0.21 in 2023, then plunged by 332.51% to 0.5 in 2024, then surged by 782.11% to 3.39 in 2025, then tumbled by 70.29% to 1.01 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 1.01, 3.39, and 0.75 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.28 Bn | 165.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.89 |
| Mar 31, 2026 | 1.01 |
| Dec 31, 2025 | 3.39 |
| Sep 30, 2025 | 0.75 |
| Jun 30, 2025 | 0.29 |
| Mar 31, 2025 | 0.57 |
| Dec 31, 2024 | -0.50 |
| Sep 30, 2024 | -0.40 |
| Jun 30, 2024 | 0.28 |
| Mar 31, 2024 | 1.11 |
| Dec 31, 2023 | 0.21 |
| Sep 30, 2023 | 0.75 |
| Jun 30, 2023 | 0.53 |
| Mar 31, 2023 | 0.43 |
| Dec 31, 2022 | 0.13 |
| Sep 30, 2022 | -0.14 |
| Jun 30, 2022 | -0.37 |
| Mar 31, 2022 | -0.56 |
| Dec 31, 2021 | -5.32 |
| Sep 30, 2021 | -0.12 |